Zentalis Pharmaceuticals Inc (ZNTL)
13.29
+0.28
(+2.15%)
USD |
NASDAQ |
Apr 23, 10:35
Zentalis Pharmaceuticals Cash from Investing (TTM): -44.46M for Dec. 31, 2023
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
Date | Value |
---|---|
December 31, 2023 | -44.46M |
September 30, 2023 | -14.29M |
June 30, 2023 | 123.18M |
March 31, 2023 | -91.86M |
December 31, 2022 | -114.18M |
September 30, 2022 | -59.02M |
June 30, 2022 | -220.48M |
March 31, 2022 | -11.78M |
December 31, 2021 | -18.12M |
Date | Value |
---|---|
September 30, 2021 | -71.03M |
June 30, 2021 | -67.48M |
March 31, 2021 | -271.34M |
December 31, 2020 | -284.83M |
September 30, 2020 | -275.22M |
June 30, 2020 | -137.44M |
March 31, 2020 | -0.342M |
December 31, 2019 | -0.352M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
-284.83M
Minimum
Dec 2020
123.18M
Maximum
Jun 2023
-91.71M
Average
-67.48M
Median
Jun 2021
Cash from Investing (TTM) Benchmarks
Revolution Medicines Inc | -342.60M |
Day One Biopharmaceuticals Inc | 128.38M |
Perspective Therapeutics Inc | 24.37M |
Electromed Inc | -1.219M |
Xtant Medical Holdings Inc | -24.78M |